|
CN105924369A
|
|
Preparation method of N-(t-butoxy carbonyl)-L-leucine-N'-methoxy-N'-methylformamide intermediate
|
|
CN105921469A
|
|
Sample bottle washing auxiliary device
|
|
CN105919927A
|
|
Apremilast oral liquid and preparation method thereof
|
|
CN105924389A
|
|
Preparation method of regorafenib intermediate
|
|
CN105919936A
|
|
Long-circulation docetaxel submicron emulsion and preparation method thereof
|
|
CN105919972A
|
|
Nanoparticles preparation encapsulated with carfilzomib, and preparation method thereof
|
|
CN105919962A
|
|
Dabigatran tablet, and preparation method and application thereof
|
|
CN105929030A
|
|
Detection method of organic impurity in pimavanserin
|
|
CN105929031A
|
|
Separation method of impurities in angiotensin receptor antagonist and NEP inhibitor compound
|
|
CN105924381A
|
|
Method for preparing pimavanserin crystal form C
|
|
CN105924500A
|
|
Carfilzomib prodrug and preparation method thereof
|
|
CN105919067A
|
|
Fish oil and lecithin compound tablet and preparation method thereof
|
|
CN105924396A
|
|
Method for preparing lorcaserin
|
